Israeli ALS treatment Gets - Fast-Track' FDA Designation

Stem cell treatment developed by Israeli company BrainStorm Cell Therapeutics has been designated by the U.S. Food and Drug Administration as a "fast-track" treatment of amyotrophic lateral sclerosis . The treatment, called NurOwn, is currently undergoing mid-stage clinical trials in Jerusalem and in the U.S. on patients with ALS, which is also known as Lou Gehrig's Disease.

http://ift.tt/1szaeac